CD4 and Arthritis: In this sense, VPAC2 has also been shown to be the predominant receptor in PBMC in early arthritis in different experimental conditions, such as activated memory Th cells, Th17-polarized cells, and proinflammatory CD4+CD28− T cells [31,32,33].